Back to Menu
Laryngeal Cancer Treatment Modalities
1.Transoral laser microsurgery
A minimally invasive approach for early-stage laryngeal cancer, enabling precise resection while maximizing preservation of laryngeal function.
2.Transoral robotic surgery
Provides a three-dimensional operative view and flexible instrument control; suitable for selected early-stage patients with high precision and rapid recovery.
3.Partial laryngectomy
Preserves laryngeal function while aiming for cure; indications should be strictly selected.
4.Total laryngectomy
Indicated for advanced or recurrent disease; postoperative voice rehabilitation and reconstructive options are available.
5.Radiotherapy
A curative modality in early-stage disease; intensity-modulated radiotherapy enables precise targeting while sparing normal tissues.
6.Concurrent chemoradiotherapy
A standard approach for locally advanced disease, enhancing radiosensitivity and improving local control.
7.Induction chemotherapy
Administered before radiotherapy to reduce tumor burden and eradicate micrometastatic disease, facilitating definitive treatment.
8.Targeted therapy
EGFR monoclonal antibodies combined with chemoradiotherapy may be used in patients with specific molecular expression profiles.
9.Immunotherapy
PD-1 inhibitors are used for recurrent or metastatic disease and can improve survival outcomes in advanced stages.
10.Functional reconstructive surgery
Flap or tissue reconstruction repairs defects and restores swallowing and airway-protective function.
11.Palliative and supportive care
Implemented throughout the treatment course to relieve symptoms and improve quality of life.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that early detection and timely treatment are pivotal for laryngeal cancer. A screening system for high-risk populations should be established. Stage-adapted individualized strategies integrating surgery, chemoradiotherapy, and targeted approaches, supported by MDT-based multidisciplinary collaboration, can improve outcomes and quality of survival.
Laryngeal Cancer Treatment Modalities
1.Transoral laser microsurgery
A minimally invasive approach for early-stage laryngeal cancer, enabling precise resection while maximizing preservation of laryngeal function.
2.Transoral robotic surgery
Provides a three-dimensional operative view and flexible instrument control; suitable for selected early-stage patients with high precision and rapid recovery.
3.Partial laryngectomy
Preserves laryngeal function while aiming for cure; indications should be strictly selected.
4.Total laryngectomy
Indicated for advanced or recurrent disease; postoperative voice rehabilitation and reconstructive options are available.
5.Radiotherapy
A curative modality in early-stage disease; intensity-modulated radiotherapy enables precise targeting while sparing normal tissues.
6.Concurrent chemoradiotherapy
A standard approach for locally advanced disease, enhancing radiosensitivity and improving local control.
7.Induction chemotherapy
Administered before radiotherapy to reduce tumor burden and eradicate micrometastatic disease, facilitating definitive treatment.
8.Targeted therapy
EGFR monoclonal antibodies combined with chemoradiotherapy may be used in patients with specific molecular expression profiles.
9.Immunotherapy
PD-1 inhibitors are used for recurrent or metastatic disease and can improve survival outcomes in advanced stages.
10.Functional reconstructive surgery
Flap or tissue reconstruction repairs defects and restores swallowing and airway-protective function.
11.Palliative and supportive care
Implemented throughout the treatment course to relieve symptoms and improve quality of life.
Conclusion
Jinshazhou Hospital of Guangzhou University of Chinese Medicine emphasizes that early detection and timely treatment are pivotal for laryngeal cancer. A screening system for high-risk populations should be established. Stage-adapted individualized strategies integrating surgery, chemoradiotherapy, and targeted approaches, supported by MDT-based multidisciplinary collaboration, can improve outcomes and quality of survival.